Emery Bresnick (Cell and Regenerative Biology/Medicine)
Emery H. Bresnick (Director) is an expert on the development and function of blood cells in normal and malignant contexts, mechanisms of cell regulation, including epigenetics, and vascular biology. Dr. Bresnick joined the faculty of the University of Wisconsin School of Medicine and Public Health in 1994 after having engaged in postdoctoral training at the National Institutes of Health with Gary Felsenfeld and Gordon Hager. Dr. Bresnick is currently Professor of Cell and Regenerative Biology and Affiliate Professor of Medicine (Hematology/Oncology) and has received multiple awards including the Leukemia and Lymphoma Society Scholar Award. Dr. Bresnick serves, or has served, as Chair of the Red Cell Scientific Committee of the American Society of Hematology, Member of the Scientific Affairs Committee of the American Society of Hematology, Board of Directors for International Society of Experimental Hematology, Chair of the National Institutes of Health Erythrocyte and Leukocyte Biology Study Section, and editorial boards of Blood, J. Biol. Chem., Mol. Cell Biol., and Nucl. Acids Res. At the University of Wisconsin-Madison, Dr. Bresnick leads a cutting-edge multidisciplinary
research program and organizes research groups in molecular and cellular hematology and vascular biology. Dr. Bresnick developed a new course on Fundamentals of Stem Cell and Regenerative Biology, teaches graduate students in Cellular Signaling Mechanisms, and is passionate about training the next-generation of multidisciplinary research scientists/scholars.
Jing Zhang (Oncology)
Jing Zhang (Co-Director) is an expert on Ras signaling in hematopoiesis and leukemogenesis. Dr. Zhang received her Ph.D. degree at the University of Pennsylvania School of Medicine in 2001, working with Dr. Michael Granato on zebra fish neural development. She started her career in hematology as a Postdoctoral Fellow with Dr. Harvey Lodish at the Whitehead Institute for Biomedical Research. Dr. Zhang joined the faculty of the McArdle Laboratory for Cancer Research at the University of Wisconsin School of Medicine and Public Health in 2007 and is currently a tenured Associate Professor of Oncology. She has received multiple awards including Postdoctoral Fellow and Scholar awards from Leukemia and Lymphoma Society, Howard Temin award from National Cancer Institute, Scholar award from American Society for Hematology, and V Scholar award from V Foundation for Cancer Research. At the University of Wisconsin School of Medicine and Public Health, Dr. Zhang leads a multidisciplinary research program and collaborates with many principle investigators from basic science and clinical departments to study the molecular, cellular, and signaling mechanisms of leukemia and develop innovative therapeutics to treat these malignancies.
Dr. Bresnick’s and Dr. Zhang’s research programs aim to generate novel discoveries that can be translated into strategies to improve the diagnosis and treatment of blood diseases. The leadership of the Blood Research Program has considerable interest in personalized/precision medicine. Strategic efforts are underway to innovate new personalized/precision medicine applications in the context of blood diseases.